About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

MR and Inflammation After Preeclampsia

NCT07345845·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Anna Stanhewicz, PhD

Age

18–45

Sex

FEMALE

Healthy volunteers

Accepted

You may be eligible if

women who had preeclampsia and women who did not have preeclampsia
12 weeks to 5 years postpartum
18-45 years old

You may not be if

history of hypertension or metabolic disease before pregnancy
history of gestational diabetes
history of gestational hypertension without preeclampsia
skin diseases
current tobacco use
current antihypertensive medication
statin or other cholesterol-lowering medication
currently pregnant
body mass index less than 18.5 kg/m2
allergy to materials used during the experiment.(e.g. latex),
known allergy to study drugs or salt-supplement

The record

StatusActive not recruiting

PhaseEarly phase 1

Taking part40

StartedDec 2025

UpdatedJan 16, 2026

Conditions

Preeclampsia Preeclampsia Postpartum

Where1

University of Iowa
Iowa City, Iowa, United States

Clareo Health | MR and Inflammation After Preeclampsia